These 4 Biotech Penny Stocks Are Buys, According to Analysts

Today’s article highlights four biotech penny stocks that are buys, according to analysts, including names from what the author regards as the “one group of biotech stocks to watch outside of COVID-related names”: cancer stocks. For these four biotech penny stocks with upside to analyst price targets ranging from 42% to 291% – CLICK HERE.